• $258.6M
    Market Cap
  • 5.08%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-18.2M
+40.52%
-12.9M
-16.01%
-15.4M
+16.28%
-13.2M
N/A
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
9.4M
+35.96%
6.9M
-7.82%
7.5M
+25.14%
6.0M
N/A
Operating Profit
-27.6M
+38.93%
-19.8M
-13.32%
-22.9M
+19.04%
-19.2M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-28.9M
+51.95%
-19.0M
-14.65%
-22.3M
+16.64%
-19.1M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-26.4M
+39.17%
-19.0M
-14.65%
-22.3M
+16.64%
-19.1M
N/A
Net Income from Continuing Operations Applicable to Common
-28.9M
+51.95%
-19.0M
-14.65%
-22.3M
+16.64%
-19.1M
N/A
Basic EPS and Net Income
-1.32
+18.92%
-1.11
-22.38%
-1.43
-5.30%
-1.51
N/A
Diluted EPS and Net Income
-1.32
+18.92%
-1.11
-22.38%
-1.43
-5.30%
-1.51
N/A
Basic Weighted Average Shares
21.8M
+27.46%
17.1M
+10.01%
15.6M
+22.90%
12.7M
N/A
Diluted Weighted Average Shares
21.8M
+27.46%
17.1M
+10.01%
15.6M
+22.90%
12.7M
N/A
Balance Sheet
Cash and Cash Equivalents
31.6M
+70.69%
18.5M
-3.10%
19.1M
-4.34%
20.0M
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
31.6M
+70.69%
18.5M
-3.10%
19.1M
-4.34%
20.0M
N/A
Total Current Assets
31.7M
+70.41%
18.6M
-3.01%
19.2M
-5.98%
20.4M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
824,000
N/A
Total Assets
31.7M
+70.41%
18.6M
-3.01%
19.2M
-5.98%
20.4M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
13.3M
+49.49%
8.9M
+27.35%
7.0M
+12.90%
6.2M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
824,000
N/A
Total Liabilities
13.3M
+49.49%
8.9M
+27.35%
7.0M
+12.90%
6.2M
N/A
Retained Earnings
-99.7M
+36.10%
-73.2M
+35.03%
-54.2M
+69.60%
-32.0M
N/A
Total Stockholders Equity
0
-100.00%
9.7M
-20.39%
12.2M
-14.19%
14.2M
N/A
Total Shares Outstanding
25.7M
+31.71%
19.5M
+11.92%
17.4M
+18.96%
14.6M
N/A
Cash Flow
Cash from Operating Activities
-16.0M
+30.72%
-12.2M
-23.24%
-16.0M
+17.66%
-13.6M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
0
N/A
0
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
29.1M
+149.79%
11.7M
-22.75%
15.1M
-45.75%
27.8M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-105.10%
+4.53%
-100.55%
-10.58%
-112.45%
N/A
N/A
N/A
Return on Equity
-544.47%
+213.99%
-173.41%
+2.91%
-168.51%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.38
+14.00%
2.09
-23.84%
2.75
N/A
N/A
N/A
Cash Ratio
2.38
+14.18%
2.08
-23.91%
2.74
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow